Plasma Metanephrines
[Plasma Metanephrines]
EPTIS factsheet 1616034 | Last revision 2026-09-24 | URL: https://www.eptis.bam.de/pts1616034 https://www.eptis.bam.de/pts1616034
| PT provider | |||||||||||||
| PT provider | Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust | ||||||||||||
| Based in | United Kingdom | ||||||||||||
| Language(s) | English | ||||||||||||
| Remarks | Provides EQA coverage for Plasma Metanephrines, this includes the anaytes Metanephrine, Normetanephrones and 3 Methoyxtyramine. The plasma metanephrines test is used for the presumptive diagnosis of catecholamine-secreting phaeochromocytomas or paragangliomas. The measurement of plasma metanephrines has been shown to be a highly sensitive test for the detection of phaeochromocytoma - a negative test result virtually rules out the diagnosis. Testing may also be used when a tumour has been treated or removed to monitor for recurrence. The scheme provides both endogenous and manipulated Lyphophised specimens to cover both the normal and pathological concentration ranges. | ||||||||||||
| Keywords | |||||||||||||
| Product groups |
Health care / medical devices
|
||||||||||||
| Testing fields |
Medical analysis
|
||||||||||||
| Technical details | |||||||||||||
|
|||||||||||||
| Aims of the PT scheme | |||||||||||||
| Target group of participants | Clinical Chemistry Public & Private Labs | ||||||||||||
| Linked to specific legislation / standards | ISO/IEC 17043:2023 | ||||||||||||
| Additional, subsidiary aims | Post market surveillance of testing methods | ||||||||||||
| Number of participants | |||||||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by UKAS on the basis of ISO/IEC 17043:2023 |
||||||||||||
| Operation is commissioned / requested by | |||||||||||||
| Fees and frequency | |||||||||||||
| Participation fee | Contact provider for current fee, which depends on location and extent of service required. | ||||||||||||
| Regularly operated | Yes (Monthly (11 per year)) | ||||||||||||
| Year of first operation | 2023 | ||||||||||||
| Contact details of the PT provider | |||||||||||||
| Provider | Contact person | ||||||||||||
|
Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust
Queen Elizabeth Medical Centre P O Box 3909 B15 2SQ Birmingham United Kingdom Phone: +44 121 414 7300 Fax: Web: https://www.birminghamquality.org.uk https://www.birminghamquality.org.uk |
Birmingham Quality
Phone: +44 121 414 7300 Fax: Email: birminghamquality@uhb.nhs.uk birminghamquality@uhb.nhs.uk |
||||||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.